Friends of Cancer Research

EIN: 521983273 501(c)(3) Medical Research

Washington, DC

Total Revenue
$7,186,730
Total Expenses
$5,245,007
Total Assets
$19,663,708
Net Assets
$15,835,795
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1996
Legal Domicile
DC
Phone
2029446700
Tax Period
2023-01-01 to 2023-12-31

Friends of Cancer Research, founded in 1996, is a community nonprofit in the Medical Research sector that reported $7.2M in total revenue in fiscal year 2023. The organization ran a surplus of $1.9M, a strong 27% operating margin.

Mission

TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $6,891,086
Program Service Revenue $0
Investment Income $295,644
Other Revenue $0
TOTAL REVENUE $7,186,730

Expense Breakdown

Grants Paid $0
Salaries & Benefits $2,755,003
Fundraising Expenses $723,966
Program Expenses $3,394,650
Other Expenses $2,490,004
TOTAL EXPENSES $5,245,007

Year-over-Year Comparison

2023 2022 Change
Revenue $7,186,730 $6,784,533 +0.1%
Expenses $5,245,007 $4,975,120 +0.1%
Net Income $1,941,723 $1,809,413 +0.1%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
15
Independent Members
14
Employees
13
Volunteers
15

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
8
$738,623
Total Directors
15
$738,623
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Jeff Allen PhD President & CEO 40.00
Officer Director
$622,957 $115,666 $738,623
Ryan Hohman JD VP-Public Affairs 40.00
$285,934 $20,833 $306,767
Mark Stewart PhD VP-Science Policy 40.00
$258,113 $16,275 $274,388
Heather Chaney VP-Operations 40.00
$207,967 $20,012 $227,979
Hillary Andrews Dir.-Reg & Res Par 40.00
$161,668 $16,303 $177,971
linda ostermann Dir.-Grant & Oper 40.00
$150,093 $14,773 $164,866
Brittany McKelvey Dir.-Reg Affairs 40.00
$132,947 $5,623 $138,570
Pennie Abramson PhD Director 0.50
Director
$0 $0 $0
Carolyn Aldige Director 0.50
Director
$0 $0 $0
Anna D Barker PhD Exec. Committee 0.50
Officer Director
$0 $0 $0
Edward Sanghyun Kim MD MBA Director 0.50
Director
$0 $0 $0
Roy Herbst MD PhD Director 0.50
Director
$0 $0 $0
Ellen Sigal PhD Chair & Founder 0.50
Officer Director
$0 $0 $0
Marlene Malek RN Vice Chair 0.50
Officer Director
$0 $0 $0
Sudip Parikh PhD Exec. Committee 0.50
Officer Director
$0 $0 $0
Margaret Foti PhD MD Exec. Committee 0.50
Officer Director
$0 $0 $0
David Mitchell Exec. Committee 0.50
Officer Director
$0 $0 $0
Richard Schilsky MD Exec. Committee 0.50
Officer Director
$0 $0 $0
Elizabeth Thompson Director 0.50
Director
$0 $0 $0
Edward J Benz Jr MD Director 0.50
Director
$0 $0 $0
Margaret Anderson Director 0.50
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $7,186,730 $5,245,007 $19,663,708 $1,941,723
2022 $6,784,533 $4,975,120 $13,380,551 $1,809,413
2021 $5,525,309 $3,563,423 $13,600,990 $1,961,886
2020 $4,973,258 $3,566,774 $10,464,081 $1,406,484
2019 $5,295,880 $3,786,105 $8,476,969 $1,509,775
2018 $4,413,385 $3,516,178 $6,367,801 $897,207
Explore More Nonprofits
→Top 100 Nonprofits in District of Columbia →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare Friends of Cancer Research with other nonprofits in District of Columbia and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.